UBS raises Cardinal Health stock target to USD 295 from USD 280
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
UBS has increased its stock target for Cardinal Health to USD 295 from USD 280, maintaining a Buy rating. This adjustment follows Cardinal Health's extended distribution agreement with CVS Health and reaffirmation of strong fiscal 2027 earnings growth guidance. The company is set to release its first-quarter fiscal 2027 results on November 5, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.